📊 GKOS Key Takeaways
Is GLAUKOS Corp (GKOS) a Good Investment?
GKOS demonstrates strong revenue growth (32.3% YoY) and exceptional gross margins (77.9%), indicating a fundamentally sound business model with pricing power. However, significant operational challenges persist with operating losses (-13.2% margin) and negative operating cash flow (-12.5M), suggesting the company is in a costly growth/investment phase. A strong balance sheet (104.2M cash, minimal debt) provides financial runway, but profitability and cash flow inflection points are critical for long-term viability.
Glaukos shows robust revenue growth and solid gross margins, but continues to post sizable operating and net losses with negative free cash flow. A strong, low-leverage balance sheet reduces near‑term solvency risk, yet the path to operating leverage remains unproven. Maintain a HOLD pending clear progress toward positive operating cash flow and improving operating margins.
Why Buy GLAUKOS Corp Stock? GKOS Key Strengths
- Strong revenue growth of 32.3% YoY demonstrates market demand and successful commercialization
- Exceptional gross margin of 77.9% indicates strong pricing power, product quality, and sustainable business model
- Fortress balance sheet with 104.2M cash, minimal debt (3.0M), and excellent liquidity ratios (5.43x current ratio)
- 32% YoY revenue growth indicating strong demand
- Healthy 55.7% gross margin supporting attractive unit economics
- Strong liquidity and minimal leverage (current ratio 4.69x, low debt)
GKOS Stock Risks: GLAUKOS Corp Investment Risks
- Negative operating cash flow (-12.5M) and negative free cash flow (-16.5M) indicate operational cash burn despite revenue growth
- Operating losses of -19.9M with -13.2% margin suggest SG&A and R&D expenses are misaligned with revenue trajectory
- Unsustainable burn rate: at current -16.5M FCF, cash runway limited; path to profitability must be demonstrated soon
- Persistent operating losses and -39.3% operating margin
- Negative operating and free cash flow may necessitate future capital needs
- Execution risk in scaling while controlling R&D/SG&A to achieve operating leverage
Key Metrics to Watch
- Operating cash flow inflection point and timeline to positive OCF
- Operating margin expansion trajectory and cost structure optimization
- Cash burn rate sustainability and quarters of remaining runway
- Operating cash flow trend toward positive
- Operating margin improvement (opex as % of revenue)
GLAUKOS Corp (GKOS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 5.43x current ratio provides a solid financial cushion.
GKOS Profit Margin, ROE & Profitability Analysis
GKOS vs Healthcare Sector: How GLAUKOS Corp Compares
How GLAUKOS Corp compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is GLAUKOS Corp Stock Overvalued? GKOS Valuation Analysis 2026
Based on fundamental analysis, GLAUKOS Corp has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
GLAUKOS Corp Balance Sheet: GKOS Debt, Cash & Liquidity
GKOS Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: GLAUKOS Corp's revenue has grown significantly by 73% over the 5-year period, indicating strong business expansion. The most recent EPS of $-2.78 indicates the company is currently unprofitable.
GKOS Revenue Growth, EPS Growth & YoY Performance
GKOS Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $106.7M | -$18.1M | $-0.32 |
| Q3 2025 | $96.7M | -$16.2M | $-0.28 |
| Q2 2025 | $95.7M | -$19.7M | $-0.34 |
| Q1 2025 | $85.6M | -$18.1M | $-0.32 |
| Q3 2024 | $78.0M | -$21.4M | $-0.39 |
| Q2 2024 | $80.4M | -$32.8M | $-0.68 |
| Q1 2024 | $73.9M | -$34.6M | $-0.72 |
| Q3 2023 | $71.3M | -$27.6M | $-0.58 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
GLAUKOS Corp Dividends, Buybacks & Capital Allocation
GKOS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for GLAUKOS Corp (CIK: 0001192448)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| May 18, 2026 | 4 | xslF345X06/form4-05182026_110531.xml | View → |
| May 13, 2026 | 4 | xslF345X06/form4-05132026_110537.xml | View → |
| May 4, 2026 | 4 | xslF345X06/form4-05042026_100528.xml | View → |
| May 4, 2026 | 4 | xslF345X06/form4-05042026_100505.xml | View → |
| May 4, 2026 | 4 | xslF345X06/form4-05042026_100551.xml | View → |
❓ Frequently Asked Questions about GKOS
What is the AI rating for GKOS?
GLAUKOS Corp (GKOS) has a Combined AI Rating of HOLD from Claude (HOLD) and ChatGPT (HOLD) with 70% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are GKOS's key strengths?
Claude: Strong revenue growth of 32.3% YoY demonstrates market demand and successful commercialization. Exceptional gross margin of 77.9% indicates strong pricing power, product quality, and sustainable business model. ChatGPT: 32% YoY revenue growth indicating strong demand. Healthy 55.7% gross margin supporting attractive unit economics.
What are the risks of investing in GKOS?
Claude: Negative operating cash flow (-12.5M) and negative free cash flow (-16.5M) indicate operational cash burn despite revenue growth. Operating losses of -19.9M with -13.2% margin suggest SG&A and R&D expenses are misaligned with revenue trajectory. ChatGPT: Persistent operating losses and -39.3% operating margin. Negative operating and free cash flow may necessitate future capital needs.
What is GKOS's revenue and growth?
GLAUKOS Corp reported revenue of $150.6M.
Does GKOS pay dividends?
GLAUKOS Corp does not currently pay dividends.
Where can I find GKOS SEC filings?
Official SEC filings for GLAUKOS Corp (CIK: 0001192448) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is GKOS's EPS?
GLAUKOS Corp has a diluted EPS of $-0.34.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is GKOS a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, GLAUKOS Corp has a HOLD rating with 70% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is GKOS stock overvalued or undervalued?
Valuation metrics for GKOS: ROE of -2.9% (sector avg: 15%), net margin of -13.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy GKOS stock in 2026?
Our dual AI analysis gives GLAUKOS Corp a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is GKOS's free cash flow?
GLAUKOS Corp's operating cash flow is $-12.5M, with capital expenditures of $4.0M. FCF margin is -10.9%.
How does GKOS compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -13.1% (avg: 12%), ROE -2.9% (avg: 15%), current ratio 5.43 (avg: 2).